Ljudmila Anatol'EVna Katargina

Ljudmila Anatol'EVna Katargina

Auto-generated profile, based on publicly available information

Ljudmila Anatol'EVna Katargina

Helmholtz National Medical Research Center of Eye Diseases

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
NNN.V. Neroeva
N.V. Neroeva
VNV.V. Neroev
V.V. Neroev
LKL.A. Katargina
L.A. Katargina
MRM.V. Ryabina
M.V. Ryabina
PIP.A. Ilyukhin
P.A. Ilyukhin
MLMaria Lagarkova
Maria Lagarkova
ЦЕЛЬ ИССЛЕДОВАНИЯ Разработать и оценить результаты модифицированной хирургической техники трансплантации индуцированных плюрипотентных стволовых клеток ретинального пигментного эпителия (ИПСК-РПЭ) в виде клеточной суспензии в субретинальное пространство кроликов с предварительно созданной атрофией РПЭ. МАТЕРИАЛ И МЕТОДЫ Материалом исследования послужили 10 кроликов (20 глаз) породы новозеландский альбинос. Спустя 1 мес после моделирования атрофии РПЭ и дегенерации сетчатки кроликам проводилась субретинальная трансплантация ИПСК-РПЭ в виде клеточной суспензии. Для предотвращения рефлюкса ИПСК-РПЭ в витреальную полость место введения клеток герметизировали с помощью 2—3 капель аутологичной плазмы, обогащенной тромбоцитами (Platelet-rich plasma, PRP). Всем кроликам проводились спектральная оптическая когерентная томография и исследование аутофлюоресценции с помощью прибора Heidelberg Spectralis SD-OCT («Heidelberg Engineering», Германия). Энуклеированные глаза животных подвергались морфологическому и иммуногистохимическому исследованиям. РЕЗУЛЬТАТЫ Разработана и проведена оценка модифицированной хирургической техники трансплантации ИПСК-РПЭ в виде клеточной суспензии в субретинальное пространство кроликов с предварительно созданной атрофией РПЭ. Установлено, что использование PRP способствует герметизации дефекта и предупреждает рефлюкс трансплантируемых клеток в витреальную полость, тем самым минимизируя интра- и послеоперационные осложнения. Морфологическое исследование in vivo и изучение гистологических срезов показали, что трансплантируемые ИПСК-РПЭ правильно интегрированы и адгезированы к сосудистой оболочке в зоне оперативного вмешательства. По результатам иммуногистохимического анализа с использованием флюоресцентно меченных антител была подтверждена жизнеспособность ИПСК-РПЭ, интегрированных в сетчатку глаза модельного животного. ЗАКЛЮЧЕНИЕ Данный способ позволяет усовершенствовать технологии трансплантации ИПСК-РПЭ на доклинических этапах исследования, что открывает новые перспективы в лечении дегенеративных заболеваний сетчатки и возможности персонифицированного подхода.

1 January 2019 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
PDF file
LKL. A. Katargina
L. A. Katargina
TKT. B. Kruglova
T. B. Kruglova
OTO. B. Trifonova
O. B. Trifonova
NEN. S. Egiyan
N. S. Egiyan
LKL. V. Kogoleva
L. V. Kogoleva
NAN. N. Arestova
N. N. Arestova
Medical article медицинская статья

4 September 2020 in Rheumatology Science and Practice
Verified
Journal Article
Open access
PDF file
TLT. A. Lisitsyna
T. A. Lisitsyna
ZAZ. S. Alekberova
Z. S. Alekberova
GDGalina A. Davidova
Galina A. Davidova
Tatiana Magomedalievna ReshetnyakTatiana Magomedalievna Reshetnyak
Tatiana Magomedalievna Reshetnyak
LKL. A. Katargina
L. A. Katargina
ENE. L. Nasonov
E. L. Nasonov
Non-infectious uveitis is the leading and insufficiently studied cause of irreversible decline in visual functions in patients with immune-mediated inflammatory rheumatic disease (IMIRDs). A multidisciplinary approach to the diagnosis and treatment of uveitis in patients with IMIRDs, involving close collaboration of rheumatologists and ophthalmologists, is the key factor for achieving favorable clinical outcomes. This article sheds light on current clinical, differential diagnostic and therapeutic challenges related to non-infectious uveitis in IMIDs-patients, with specific emphasis on state-of-the art approaches to therapy.

4 April 2021 in Ophthalmology in Russia
Verified
Journal Article
Open access
PDF file
LKL. A. Katargina
L. A. Katargina
EDE. N. Demchenko
E. N. Demchenko
LKL. V. Kogoleva
L. V. Kogoleva
The clinical course of active retinopathy after anti-VEGF therapy, the possibility and timing of recurrence of the disease, anatomical and functional outcomes of treatment are widely discussed in the press, not fully studied and relevant.Purpose: to study the clinical course of active retinopathy of prematurity after anti-VEGF therapy and clinical and functional outcomes.Patients and Methods. Children with active retinopathy of prematurity, who turned to the Helmgoltz National Medical Research Centre of Eye Diseases after anti-VEGF therapy, examined by indirect binocular ophthalmoscopy and digital retinal camera (RetcamShuttle). Children were monitored from 1.5 to 6 years (average 2.94 ± 1.47). All children underwent routine examination, 4 children older than 3 years underwent optical coherence tomography.Results. In all cases, after anti-VEGF therapy, there was a decrease in vascular activity and continued vascularization of the retina. Recurrence of the disease requiring additional treatment, were detected in 11 (42.3 %) eyes within 6–22 weeks (in average 13.33 ± 5.57) after intravitreal anti-VEGF therapy. Laser coagulation of the retina was carried out in 4 children (7 eyes) and repeated administration of anti-VEGF drug — 2 children (4 eyes), which led to regression of the disease. In the long-term period, all 13 (100 %) children had successful outcomes.Conclusion. Anti-VEGF therapy is effective in plus-zone 1 disease and posterior aggressive retinopathy of prematurity. Its advantages include the ability to treat retinopathy in zone 1 posterior, the absence of “blockade” of the peripheral retina with the possibility of continued growth of blood vessels to the periphery, lower frequency and severity of myopia. The disadvantages include the possibility of recurrence of the disease, which requires long-term regular monitoring.

9 October 2022 in Ophthalmology in Russia
Verified
Journal Article
Open access
PDF file
APA. V. Pleskova
A. V. Pleskova
LKL. A. Katargina
L. A. Katargina
EIElena N. Iomdina
Elena N. Iomdina
APA. Yu. Panova
A. Yu. Panova
IMI. R. Mamakaeva
I. R. Mamakaeva
ASA. A. Sorokin
A. A. Sorokin
Ulcerative lesions of the cornea and graft in children are a serious problem in pediatric ophthalmology, leading to serious consequences, up to the anatomical death of the eye. The problem of effective treatment of this pathology and corneal tissue regeneration in children remains relevant, despite the large arsenal of drugs. Recently, ultraviolet (UVA) corneal collagen crosslinking has been proposed as an alternative treatment for corneal ulcers in adults. RASK-CXL is the official name used exclusively for crosslinking in cornea inflammatory diseases. In children, corneal collagen crosslinking is still used only for the treatment of keratoconus. We were the first to use this method to treat corneal ulcers and graft ulcers in children.Purpose: to analyze the results of treatment of ulcerative corneal lesions and graft in children using a new device for local UVA crosslinking.Material and methods. For dynamic observation of patients, biomicroscopy with a fluorescein test, photo registration and optical coherence tomography of the eye anterior part were used. The procedure of local UVA crosslinking for the treatment cornea ulcerative lesions was carried out using a new device on the basis of the permission of the Ethics Committee of the National Medical Reseach Center of eye deseases named after Helmholtz of the Ministry of Health of Russia (protocol No. 56 of 21.10.2021).Results. The use of 3–5 procedures of local UVA exposure (against the background of instillations of 0.1 % riboflavin solution) lasting 5–7 minutes with an interval of 1-3 days ensured epithelization of the cornea and the graft and increased visual acuity in children.Conclusion. The first treatment results of corneal ulcers and graft in children using a new portable device for local UVA crosslinking have shown its high therapeutic efficiency and prospects for further use in clinical practice.

15 September 2017 in Russian Pediatric Ophthalmology
Verified
Journal Article
Open access
PDF file
LKL. A Katargina
L. A Katargina
NONatal’ya Anatol’evna Osipova
Natal’ya Anatol’evna Osipova
КАКатаргина Л. А
Катаргина Л. А
ОАОсипова Наталья Анатольевна
Осипова Наталья Анатольевна
Retinopathy of prematurity continues to occupy one of the leading positions in the structure of vision disability among the children. The problem of optimizing the prognosis of this condition, its early diagnostics, and adequate treatment remains a serious challenge and is inextricably connected with the better understanding of the pathogenesis of this disease. It is known that the mechanism underlying the development of retinopathy of prematurity involves the imbalance between the angiogenic factors controlling the process of growth and development of blood vessels in the immature retinal tissue in the combination with the biochemical and immunological disturbances of homeostasis in the prematurely born infants as a result of systemic somatic pathology and the unfavourable multifactorial influence of the environmental conditions, in the first place the effect of elevated oxygen concentrations used for the nursing the preterm babies. A large number of papers have been devoted to the study of various factors contributing to the development of retinopathy in preterm patients at the molecular level. For the purpose of the present review, the search for the relevant literature was carried out using the Medline database. The role of the vascular endothelial growth factor (VEGF-A) and insulin-like growth factor-1 (IGF-1) in the development of pathological vasoproliferation associated with retinopathy of prematurity has been most thoroughly explored. Information about the role of VEGF-A in the pathogenesis of the disease provided the basis for the use of anti-VEGF therapy in the clinical practice for the treatment of certain forms of retinopathy. However, the complicated and multifactorial character of the pathogenesis of this disease as well as the need for the enhancement of the effectiveness of its treatment and optimization of the screening procedure dictates the necessity of looking for additional approaches to the solution of this problem and of studying the relationships between various factors involved in the disturbance of retinal angiogenesis in the children presenting with retinopathy of prematurity.